Strategic Advisory Board

Sir Norman is one of the most widely respected figures in British medicine, with a career that has spanned frontline surgery, national clinical leadership, and health policy at the highest level. He is currently an advisory body to the Secretary of State for Health and Social Care and Chair of the National Clinical Improvement Programme.

A former President of the Royal College of Surgeons of England and Emeritus Professor of Surgery at Barts and The London, Sir Norman has served as senior clinical adviser to the Secretary of State for Health, chaired the Health Education England Commission on Training for Patient Safety, and co-chaired the Duty of Candour Review. He was knighted for services to surgery in 2015.

Annabel is Medica’s Group Chief Medical Officer. With over 30 years’ clinical and commercial experience, she trained originally as an NHS surgeon before moving into senior leadership roles across diagnostic and health services leading transformation programmes and specialising in addressing unwarranted variations in care.

She was formerly Executive Medical Director at InHealth, Chief Medical Officer at AXA Health, and Medical Director at Bupa UK. Annabel has extensive experience leading innovation and change across diagnostics, using data to inform decision-making, improve quality and improve outcomes for patients.

Ian is a transplant nephrologist and former Chief Executive Officer of Guy’s and St Thomas’ NHS Foundation Trust (the largest NHS Trust in England) where he led a workforce of over 23,000 and oversaw a turnover of £3.2 billion. From April 2026 he serves as interim Chief Medical Officer.

A Cambridge MBA-qualified leader with a Professorship at King’s College London, Ian brings expertise in digital transformation, genomics, life sciences partnerships, and NHS innovation at scale. He was responsible for the implementation of the EPIC clinical system at GSTT and serves on the NHS England Digital Transformation Portfolio Board.

Amrita is Medica’s Radiology and AI Clinical Lead and a consultant radiologist specialising in breast cancer and screening. She serves as an AI adviser to the Royal College of Radiologists and the British Institute of Radiology, and is an AI adviser to NHS England and the Department of Health.

She was awarded the 2024 NHS Parliamentary Award for establishing the UK’s first dedicated AI working group, and has built end-to-end AI governance frameworks and implementation platforms adopted across multiple hospital settings. A Visiting Lecturer at City University UK, she speaks internationally on AI in diagnostic pathways.

David is Clinical Director of Innovation at the University of Glasgow and an Emergency Medicine Consultant at Queen Elizabeth University Hospital. He works at the intersection of frontline clinical care, academic research and health system transformation, with a focus on translating innovation into real-world impact.

A founding member of the Centre of Excellence for Regulatory Science in AI, he contributes to national AI policy through the UK Commission for AI Regulation in Health and serves on the MHRA AI Airlock advisory board. His clinical innovation interests span diagnostics, long-term conditions and AI-driven case-finding in cancer and emergency pathways.

Susan is a Consultant Paediatric Radiologist at Great Ormond Street Hospital, NIHR Advanced Fellow, Honorary Associate Professor at University College London and Honorary Visiting Professor at City St George’s, University of London. She was awarded the Royal College of Radiologists’ Roentgen Professorship in 2025.

Named 18th in the 2025 Digital Leaders AI 100, a UK-wide ranking of the most influential figures in artificial intelligence, recognised at the House of Lords, she is one of the UK’s leading authorities on safe and effective AI adoption in healthcare. She brings expertise in how clinicians, teams and health systems respond when AI is introduced into real-world diagnostic pathways, and how organisations can design for success.

Andrew is Medica’s Group CEO, he previously served as Chief Executive Officer at Voyage Care for 8 years. Before this, he held the position of Managing Director at Bupa Care Services, where he led a team of 27,000 individuals across 300 residential homes and five care villages, providing care for 40,000 people. Prior to this, he served as Director of Healthcare Delivery at Bupa, overseeing service call centres, claims management (in the UK and India), administration services, and a network of treatment ‘Centres of Excellence’ throughout the UK.